These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31385643)

  • 1. Bridging Crystal Engineering and Drug Discovery by Utilizing Intermolecular Interactions and Molecular Shapes in Crystals.
    Spackman PR; Yu LJ; Morton CJ; Parker MW; Bond CS; Spackman MA; Jayatilaka D; Thomas SP
    Angew Chem Int Ed Engl; 2019 Nov; 58(47):16780-16784. PubMed ID: 31385643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of small-molecule structures to complement protein-ligand crystal structures in drug discovery.
    Groom CR; Cole JC
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):240-245. PubMed ID: 28291759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using more than 801 296 small-molecule crystal structures to aid in protein structure refinement and analysis.
    Cole JC; Giangreco I; Groom CR
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):234-239. PubMed ID: 28291758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life-science applications of the Cambridge Structural Database.
    Taylor R
    Acta Crystallogr D Biol Crystallogr; 2002 Jun; 58(Pt 6 No 1):879-88. PubMed ID: 12037325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design.
    Skalic M; Sabbadin D; Sattarov B; Sciabola S; De Fabritiis G
    Mol Pharm; 2019 Oct; 16(10):4282-4291. PubMed ID: 31437001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CSD Drug Subset: The Changing Chemistry and Crystallography of Small Molecule Pharmaceuticals.
    Bryant MJ; Black SN; Blade H; Docherty R; Maloney AGP; Taylor SC
    J Pharm Sci; 2019 May; 108(5):1655-1662. PubMed ID: 30615878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of physicochemical data and small-molecule crystallographic contact propensities to predict interactions in protein binding sites.
    Nissink JW; Taylor R
    Org Biomol Chem; 2004 Nov; 2(22):3238-49. PubMed ID: 15534701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Assessment of Torsional Strain in Crystal Structures of Small Molecules and Protein-Ligand Complexes using ab Initio Calculations.
    Rai BK; Sresht V; Yang Q; Unwalla R; Tu M; Mathiowetz AM; Bakken GA
    J Chem Inf Model; 2019 Oct; 59(10):4195-4208. PubMed ID: 31573196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the protein-ligand interaction energy for model building and validation.
    Beshnova DA; Pereira J; Lamzin VS
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):195-202. PubMed ID: 28291754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Protein-Ligand Crystal Structure Models: Small Molecule and Peptide Ligands.
    Pozharski E; Deller MC; Rupp B
    Methods Mol Biol; 2017; 1607():611-625. PubMed ID: 28573591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
    Larsson A; Jansson A; Åberg A; Nordlund P
    Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein X-ray Crystallography and Drug Discovery.
    Maveyraud L; Mourey L
    Molecules; 2020 Feb; 25(5):. PubMed ID: 32106588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders.
    Hughes SJ; Ciulli A
    Essays Biochem; 2017 Nov; 61(5):505-516. PubMed ID: 29118097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shaping the interaction landscape of bioactive molecules.
    Gfeller D; Michielin O; Zoete V
    Bioinformatics; 2013 Dec; 29(23):3073-9. PubMed ID: 24048355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. dMXP: A
    Ai H; Wu D; Zhou H; Xu J; Gu Q
    J Chem Inf Model; 2024 May; 64(9):3744-3755. PubMed ID: 38662925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical screening for the discovery of small-molecule ligands.
    Ciulli A
    Methods Mol Biol; 2013; 1008():357-88. PubMed ID: 23729259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore modelling as a virtual screening tool for the discovery of small molecule protein-protein interaction inhibitors.
    Voet A; Zhang KY
    Curr Pharm Des; 2012; 18(30):4586-98. PubMed ID: 22650262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating and understanding ring conformations using small molecule crystallographic data.
    Cottrell SJ; Olsson TS; Taylor R; Cole JC; Liebeschuetz JW
    J Chem Inf Model; 2012 Apr; 52(4):956-62. PubMed ID: 22372622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping small molecule binding data to structural domains.
    Kruger FA; Rostom R; Overington JP
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S11. PubMed ID: 23282026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.